Erectile Dysfunction Adverts Changing

The erectile dysfunction drug industry is changing the way it is marketing its products following negative feedback and offended sensibilities over previous efforts at promoting ED drugs using risque and cheeky advertisments. The big drug companies that make Levitra, Cialis and Viagra realised that they must promote erectile dysfunction as a medical condition in the adverts and not try to make the drugs sound like lifestyle supplements.

In fact the erectile dysfunction drug market has not grown significantly following the adverts and along with the criticism leveled at the manufacturers for not always treating erectile dysfunction seriously the industry is having to change its marketing focus and strategy. Nearly all the big manufacturers have resorted to promoting information and facts about erectile dysfunction rather then the drugs themselves. They are treating their advert campaigns as awareness projects designed to get people talking about the erectile dysfunction problem.

The impotence drugs market last year failed to grow in America according to some analysts and Viagra lost more market share to some of its rivals namely Cialis and Levitra. The erectile dysunction market could still grow in the US and worldwide but the approach to the marketing of the drugs is crucial as impotence in men is a very sensitive subject and must be approached very carefully and with awareness of cultural sensitivities.

Estimates of the number of erectile dysfunction sufferers in America vary from 25 to 35 million men and this many analysts feel is the reason why the market for growth is still largely untapped. However not all of these impotent men want to have sexual intercourse regularily for various reason and others have learnt to live with their erectile dysfunction. With this in mind the potential for the sales of the ED drugs Viagra, Levitra and Cialis is considerably smaller and is very difficult to evaluate exactly.